Ultragenyx Pharmaceutical | Kostnadene For Salg



Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Insmed USD 26.15M 4.98M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Kyowa Hakko Kirin JPY 34.54B 657M 2024-09
MacroGenics USD 1.87M 953K 2024-09
Moderna USD 546M 246M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Ultragenyx Pharmaceutical Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.